+Search query
-Structure paper
Title | Targeting a neoantigen derived from a common TP53 mutation. |
---|---|
Journal, issue, pages | Science, Vol. 371, Year 2021 |
Publish date | Mar 12, 2020 (structure data deposition date) |
Authors | Hsiue, E.H. / Wright, K.M. / Douglass, J. / Hwang, M.S. / Mog, B.J. / Pearlman, A.H. / Paul, S. / DiNapoli, S.R. / Konig, M.F. / Wang, Q. ...Hsiue, E.H. / Wright, K.M. / Douglass, J. / Hwang, M.S. / Mog, B.J. / Pearlman, A.H. / Paul, S. / DiNapoli, S.R. / Konig, M.F. / Wang, Q. / Schaefer, A. / Miller, M.S. / Skora, A.D. / Azurmendi, P.A. / Murphy, M.B. / Liu, Q. / Watson, E. / Li, Y. / Pardoll, D.M. / Bettegowda, C. / Papadopoulos, N. / Kinzler, K.W. / Vogelstein, B. / Gabelli, S.B. / Zhou, S. |
External links | Science / PubMed:33649166 |
Methods | X-ray diffraction |
Resolution | 3.53 Å |
Structure data | PDB-6w51: |
Chemicals | ChemComp-PO4: ChemComp-HOH: |
Source |
|
Keywords | IMMUNE SYSTEM / Immunotherapy / MHC-I / HLA-A2 / p53 |